Rare lephants
Screener

Damora Therapeutics, Inc.

DMRA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jan 5, 2023 FORM 4 SUBMISSION
4 Jan 5, 2023 FORM 4 SUBMISSION
10-Q Nov 8, 2022 10-Q
8-K Oct 31, 2022 8-K
SC 13D/A Sep 30, 2022 SC 13D/A
8-K Sep 29, 2022 8-K
10-Q Jul 29, 2022 10-Q
8-K Jun 17, 2022 8-K
4 Jun 15, 2022 FORM 4 SUBMISSION
4 Jun 15, 2022 FORM 4 SUBMISSION
4 Jun 15, 2022 FORM 4 SUBMISSION
4 Jun 15, 2022 FORM 4 SUBMISSION
4 Jun 15, 2022 FORM 4 SUBMISSION
4 Jun 15, 2022 FORM 4 SUBMISSION
10-Q Apr 29, 2022 10-Q
DEFA14A Apr 28, 2022 DEFA14A
DEF 14A Apr 28, 2022 DEF 14A
4 Mar 23, 2022 FORM 4 SUBMISSION
4 Mar 23, 2022 FORM 4 SUBMISSION
424B5 Feb 18, 2022 424B5
S-8 Feb 17, 2022 S-8
10-K Feb 17, 2022 10-K
4 Feb 15, 2022 FORM 4 SUBMISSION
SC 13G/A Feb 14, 2022
SC 13G/A Feb 11, 2022 SCHEDULE 13G/A
← Newer Page 10 of 15 · 351 filings Older →